$LOAN
Manhattan Bridge Capital Inc

2015 Q1 Form 10-Q Financial Statement

#000114420415026878 Filed on May 01, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 Q4 2014 Q1
Revenue $911.8K $900.0K $608.9K
YoY Change 49.74% 52.54% 13.95%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $250.0K $320.0K $180.0K
YoY Change 38.89% 10.34% 5.88%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.591K $0.00
YoY Change
% of Gross Profit
Operating Expenses $260.0K $320.0K $170.0K
YoY Change 52.94% 14.29% -5.56%
Operating Profit $475.6K $316.4K
YoY Change 50.32% 22.51%
Interest Expense -$180.0K -$180.0K -$120.0K
YoY Change 50.0% 50.0% 20.0%
% of Operating Profit -37.85% -37.93%
Other Income/Expense, Net $0.00 $0.00 $10.00K
YoY Change -100.0% -100.0% 0.0%
Pretax Income $475.6K $400.0K $323.3K
YoY Change 47.12% 166.67% 21.92%
Income Tax $0.00 $0.00 $115.0K
% Of Pretax Income 0.0% 0.0% 35.57%
Net Earnings $475.6K $400.0K $208.3K
YoY Change 128.36% 566.67% 20.29%
Net Earnings / Revenue 52.16% 44.44% 34.2%
Basic Earnings Per Share $0.08 $0.05
Diluted Earnings Per Share $0.08 $65.90K $0.05
COMMON SHARES
Basic Shares Outstanding 6.088M shares 6.060M shares 4.256M shares
Diluted Shares Outstanding 6.129M shares 4.287M shares

Balance Sheet

Concept 2015 Q1 2014 Q4 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $260.0K $50.00K $0.00
YoY Change -95.1% -100.0%
Cash & Equivalents $256.3K $47.68K $931.00
Short-Term Investments
Other Short-Term Assets $52.30K $27.00K $34.29K
YoY Change 52.53% 45.6% -14.27%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $17.53M $19.43M $12.74M
YoY Change 37.63% 63.13% 32.44%
LONG-TERM ASSETS
Property, Plant & Equipment $17.50K $19.09K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $70.00K $70.00K $210.0K
YoY Change -66.67% -66.67% -16.0%
Other Assets $12.50K $0.00 $17.50K
YoY Change -28.57% -56.25%
Total Long-Term Assets $6.976M $5.017M $3.295M
YoY Change 111.72% 19.03% -8.98%
TOTAL ASSETS
Total Short-Term Assets $17.53M $19.43M $12.74M
Total Long-Term Assets $6.976M $5.017M $3.295M
Total Assets $24.51M $24.44M $16.04M
YoY Change 52.85% 51.6% 21.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $70.00K $160.0K $20.00K
YoY Change 250.0% 166.67% -66.67%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $1.096M $2.469M $1.319M
YoY Change -16.96% 87.16% 13.75%
Long-Term Debt Due $9.320M $7.700M $5.300M
YoY Change 75.85% 43.93% 65.63%
Total Short-Term Liabilities $10.64M $10.58M $6.974M
YoY Change 52.57% 46.27% 50.95%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $10.64M $10.58M $6.974M
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $10.64M $10.58M $6.970M
YoY Change 52.65% 46.33% 50.87%
SHAREHOLDERS EQUITY
Retained Earnings $113.3K -$322.0K
YoY Change -123.24%
Common Stock $14.12M $9.753M
YoY Change 44.85%
Preferred Stock
YoY Change
Treasury Stock (at cost) $369.3K $369.3K
YoY Change 0.0%
Treasury Stock Shares 177.0K shares 177.0K shares 177.0K shares
Shareholders Equity $13.87M $13.87M $9.062M
YoY Change
Total Liabilities & Shareholders Equity $24.51M $24.44M $16.04M
YoY Change 52.85% 51.6% 21.11%

Cashflow Statement

Concept 2015 Q1 2014 Q4 2014 Q1
OPERATING ACTIVITIES
Net Income $475.6K $400.0K $208.3K
YoY Change 128.36% 566.67% 20.29%
Depreciation, Depletion And Amortization $1.591K $0.00
YoY Change
Cash From Operating Activities $280.0K $500.0K -$30.00K
YoY Change -1033.33% 108.33% 50.0%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$20.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $270.0K -$880.0K -$880.0K
YoY Change -130.68% -223.94% -180.73%
Cash From Investing Activities $270.0K -$900.0K -$880.0K
YoY Change -130.68% -226.76% -180.73%
FINANCING ACTIVITIES
Cash Dividend Paid $486.7K $42.56K
YoY Change 1043.5%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -340.0K 400.0K -110.0K
YoY Change 209.09% 3900.0% -89.72%
NET CHANGE
Cash From Operating Activities 280.0K 500.0K -30.00K
Cash From Investing Activities 270.0K -900.0K -880.0K
Cash From Financing Activities -340.0K 400.0K -110.0K
Net Change In Cash 210.0K -0.00000000005821 -1.020M
YoY Change -120.59% -100.0%
FREE CASH FLOW
Cash From Operating Activities $280.0K $500.0K -$30.00K
Capital Expenditures $0.00 -$20.00K
Free Cash Flow $280.0K $520.0K
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
256282 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47676 USD
CY2015Q1 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
17006406 USD
CY2015Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
19138426 USD
CY2015Q1 us-gaap Interest Receivable Current
InterestReceivableCurrent
219299 USD
CY2014Q4 us-gaap Assets
Assets
24444317 USD
CY2014Q4 us-gaap Interest Receivable Current
InterestReceivableCurrent
213766 USD
CY2015Q1 us-gaap Other Assets Current
OtherAssetsCurrent
52304 USD
CY2014Q4 us-gaap Other Assets Current
OtherAssetsCurrent
26995 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
17534291 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
19426863 USD
CY2015Q1 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
6754550 USD
CY2014Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
4894050 USD
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17497 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19088 USD
CY2015Q1 us-gaap Security Deposit
SecurityDeposit
6816 USD
CY2014Q4 us-gaap Security Deposit
SecurityDeposit
6816 USD
CY2015Q1 us-gaap Cost Method Investments
CostMethodInvestments
65000 USD
CY2014Q4 us-gaap Cost Method Investments
CostMethodInvestments
65000 USD
CY2015Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
119638 USD
CY2014Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
32500 USD
CY2015Q1 us-gaap Assets
Assets
24510292 USD
CY2015Q1 us-gaap Short Term Borrowings
ShortTermBorrowings
1095620 USD
CY2014Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
2469465 USD
CY2015Q1 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
9316046 USD
CY2014Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
7700000 USD
CY2015Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
66061 USD
CY2015Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
90556 USD
CY2014Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
163622 USD
CY2015Q1 loan Interest And Amortization Of Debt Service Costs
InterestAndAmortizationOfDebtServiceCosts
183055 USD
CY2014Q1 loan Referral Fees
ReferralFees
109 USD
CY2015Q1 loan Referral Fees
ReferralFees
1197 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10577863 USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
6260 USD
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
14116183 USD
CY2014Q4 us-gaap Treasury Stock Value
TreasuryStockValue
369335 USD
CY2015Q1 loan Deferred Origination Fees
DeferredOriginationFees
166533 USD
CY2014Q4 loan Deferred Origination Fees
DeferredOriginationFees
244776 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
113346 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
13866454 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24444317 USD
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000 shares
CY2015Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6266089 shares
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6260689 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6089089 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
6083689 shares
CY2015Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
177000 shares
CY2014Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
177000 shares
CY2014Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount Commercial
LoansAndLeasesReceivableGrossCarryingAmountCommercial
15575950 USD
CY2015Q1 us-gaap Loans And Leases Receivable Gross Carrying Amount Commercial
LoansAndLeasesReceivableGrossCarryingAmountCommercial
23760956 USD
CY2015Q1 loan Jointly Funded Loans Total
JointlyFundedLoansTotal
4460000 USD
CY2015Q1 loan Jointly Funded Loans
JointlyFundedLoans
2342500 USD
CY2011Q1 us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
675000 USD
CY2011Q1 loan Option Sold
OptionSold
3900 USD
CY2011Q1 loan Option Monthly Fee
OptionMonthlyFee
10530 USD
CY2012Q4 loan Exercise Price Of Remaining Property
ExercisePriceOfRemainingProperty
146821 USD
CY2012Q4 loan Monthly Option Fee For Property After Partial Exercise Of Option
MonthlyOptionFeeForPropertyAfterPartialExerciseOfOption
2296 USD
CY2014Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
6887 USD
CY2014Q1 loan Interest Income From Loans
InterestIncomeFromLoans
507371 USD
CY2015Q1 loan Interest Income From Loans
InterestIncomeFromLoans
756750 USD
CY2014Q1 loan Origination Fees
OriginationFees
101539 USD
CY2015Q1 loan Origination Fees
OriginationFees
155011 USD
CY2014Q1 us-gaap Revenues
Revenues
608910 USD
CY2015Q1 us-gaap Revenues
Revenues
911761 USD
CY2014Q1 loan Interest And Amortization Of Debt Service Costs
InterestAndAmortizationOfDebtServiceCosts
116423 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
175996 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
251913 USD
CY2014Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
292528 USD
CY2015Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
436165 USD
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
316382 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
475596 USD
CY2015Q1 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
0 USD
CY2014Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
323269 USD
CY2015Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
475596 USD
CY2014Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
115000 USD
CY2015Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
208269 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
475596 USD
CY2014Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
CY2015Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2014Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
CY2015Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2014Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4256190 shares
CY2015Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
6087531 shares
CY2014Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4286673 shares
CY2015Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
6129016 shares
CY2014Q1 loan Share Based Compensation Expense
ShareBasedCompensationExpense
3416 USD
CY2015Q1 loan Share Based Compensation Expense
ShareBasedCompensationExpense
3416 USD
CY2015Q1 loan Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights For Employee And Nonemployee Directors
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsForEmployeeAndNonemployeeDirectors
The options may vest over a period not to exceed ten years. Stock options under the Plan may be awarded to officers, key-employees, consultants and non-employee directors of the Company. Under the Plan, every non-employee director of the Company is granted 7,000 options upon first taking office, and then 7,000 upon each additional year in office.
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0959 pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.595 pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0171 pure
CY2015Q1 loan Fair Value Of Restricted Shares Amortization Period
FairValueOfRestrictedSharesAmortizationPeriod
P15Y
CY2011 loan Operating Lease Term Of Lease
OperatingLeaseTermOfLease
five years and two months
CY2014Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0 USD
CY2015Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3418 USD
CY2014Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3416 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3416 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
16865 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
5532 USD
CY2014Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
15752 USD
CY2015Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
25309 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-39599 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-97560 USD
CY2014Q1 loan Increase Decrease In Deferred Origination Fees
IncreaseDecreaseInDeferredOriginationFees
8504 USD
CY2015Q1 loan Increase Decrease In Deferred Origination Fees
IncreaseDecreaseInDeferredOriginationFees
78243 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-159995 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-29030 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
277377 USD
CY2014Q1 loan Issuance Of Short Term Loans
IssuanceOfShortTermLoans
4774000 USD
CY2015Q1 loan Issuance Of Short Term Loans
IssuanceOfShortTermLoans
2807000 USD
CY2014Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
3893000 USD
CY2015Q1 us-gaap Proceeds From Principal Repayments On Loans And Leases Held For Investment
ProceedsFromPrincipalRepaymentsOnLoansAndLeasesHeldForInvestment
3078520 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-881000 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
271520 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
0 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
7260 USD
CY2014Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
42562 USD
CY2015Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
486695 USD
CY2014Q1 us-gaap Payments Of Financing Costs
PaymentsOfFinancingCosts
0 USD
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12500 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
0 USD
CY2014Q1 us-gaap Depreciation
Depreciation
0 USD
CY2015Q1 us-gaap Depreciation
Depreciation
1591 USD
CY2014Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
17500 USD
CY2015Q1 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
12500 USD
CY2014Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
30483 shares
CY2015Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
41485 shares
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
112517 shares
CY2015Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
35515 shares
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q1 dei Entity Registrant Name
EntityRegistrantName
MANHATTAN BRIDGE CAPITAL, INC
CY2015Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001080340
CY2015Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2015Q1 dei Trading Symbol
TradingSymbol
LOAN
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
6096089 shares
CY2014Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
0 USD
CY2015Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
1373846 USD
CY2014Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
-50000 USD
CY2015Q1 us-gaap Proceeds From Repayments Of Lines Of Credit
ProceedsFromRepaymentsOfLinesOfCredit
1616046 USD
CY2014Q3 loan Warrants To Purchase Common Stock
WarrantsToPurchaseCommonStock
87719 shares
CY2014Q3 loan Warrants Exercise Price
WarrantsExercisePrice
3.5625
CY2014Q3 loan Warrants Expiry Date
WarrantsExpiryDate
2019-07-28
CY2014Q3 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
42224 USD

Files In Submission

Name View Source Status
0001144204-15-026878-index-headers.html Edgar Link pending
0001144204-15-026878-index.html Edgar Link pending
0001144204-15-026878.txt Edgar Link pending
0001144204-15-026878-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
loan-20150331.xml Edgar Link completed
loan-20150331.xsd Edgar Link pending
loan-20150331_cal.xml Edgar Link unprocessable
loan-20150331_def.xml Edgar Link unprocessable
loan-20150331_lab.xml Edgar Link unprocessable
loan-20150331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v407660_10q.htm Edgar Link pending
v407660_ex31-1.htm Edgar Link pending
v407660_ex31-2.htm Edgar Link pending
v407660_ex32-1.htm Edgar Link pending
v407660_ex32-2.htm Edgar Link pending